What You Should Know:
- Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B.
- The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More
Clinical Trial Monitoring
Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials
What You Should Know:
- Reify Health, a Boston-based company paving the way to faster, predictable, and more accessible clinical trials, today announced it has raised $220M in a Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures. This latest funding brings the company’s valuation to $2.2B.
- Reify Health has built a new foundation for how clinical trials are run through its
Read More
Hawthorne Effect Secures $20M to Decentralize Clinical Trials
What You Should Know:
- Hawthorne Effect, a San Francisco-based solution for decentralizing clinical trials, today announced it has raised $20M in Series A funding led by Northpond Ventures with participation from SignalFire and P5 Health Ventures.
- Founded in 2015, Hawthrone Effect alleviates key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical professionals.
Hawthrone’s key offerings include:
- Hawthorne Cloud: The
Read More
UPenn Taps Medable’s Digital Trials Platform to Power LITE Psoriasis Study
The University of Pennsylvania School of Medicine has partnered with Medable, a provider of digital trials platform to accelerate patient enrollment and increase patient retention in the Light Treatment Effectiveness (LITE) study, which evaluates home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis.Phase 4 Pragmatic StudyMedable’s direct-to-patient app was selected for LITE, a Phase 4 pragmatic study that will enroll 1050 patients across 20-40 clinical
Read More
TriNetX Acquires European Clinical Data Network InSite
TriNetX, a global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) has acquired Belgium-based Custodix NV and its InSite network. InSite network is a European-based provider of services for clinical trial design, patient feasibility, and enabling workflow for patient recruitment. Financial details of the acquisition were not disclosed.
InSite Clinical Data Network Background
The InSite platform is an
Read More
TriNetX Lands $40M to Expand Global Health Research Network
TriNetX, a Cambridge, MA-based global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence (RWE) has raised $40 million in Series D funding. The Series D funding round was led by Merck Global Health Innovation Fund (Merck GHIF) along with new investors Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, and existing investors MPM Capital, F2 Ventures, and Deerfield Management. To date, TriNetX has raised
Read More
Microsoft Develops New Chatbot to Match Patients to Clinical Trials Easier
Microsoft has developed a clinical trials chatbot designed to optimize matching patients with appropriate clinical trials, Bloomberg first reports. By using AI-driven machine reading technology to ingest the selection criteria for each clinical trial, the chatbot uses this data to determine which questions to ask patients and matches their answers to suitable clinical trials. The chatbot initially started as a hackathon project at Microsoft’s Corp’s lab in Israel and is part of a larger
Read More
Massachusetts General Hospital to Deploy CarePassport’s Digital Health Platform for Clinical Trials
Massachusetts General Hospital, a founding hospital of Partners HealthCare, announced it will implement CarePassport's digital health platform for patient monitoring and engagement in research studies. The largest hospital-based research program in the nation selected the Boston-based company to enhance its research processes in clinical trials by enabling two-way communication with patients and collecting more structured health data throughout the patient's medical journey.CarePassport's
Read More
TriNetX Develops Algorithm for Deducing The Chemotherapy Line of Treatment
TriNetX, the global health research network representing nearly 100 million patients, has developed a groundbreaking chemotherapy lines of treatment identification algorithm that understands treatment patterns to deduce the line of chemotherapy treatment a patient is undergoing. This information, up to now nearly impossible to obtain, is critical for biopharmaceutical companies striving to develop therapies for patients involved in care regimens beyond first line treatments.Chemotherapy lines
Read More
DrFirst Acquires VisibilityRx to Optimize Clinical Trial Recruitment
DrFirst, a provider of electronic prescribing, integrated medication management and secure communication for healthcare has acquired Duluth, GA-based VisibilityRx, a provider of clinical trial recruitment services to life sciences, clinical research organizations and pharmacies. Financial terms of the acquisition were not disclosed. For DrFirst, the acquisition provides 60,000 physician clients the ability to easily identify and refer their patients to the latest clinical trials and
Read More
